Bank of New York Mellon Corp - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,054,602
-11.9%
278,959
+6.5%
0.00%0.0%
Q2 2023$3,467,145
-2.8%
261,869
-0.0%
0.00%0.0%
Q1 2023$3,565,207
-33.5%
261,955
-4.5%
0.00%0.0%
Q4 2022$5,358,505
+31.2%
274,373
+28.0%
0.00%0.0%
Q3 2022$4,083,000
+9.8%
214,291
+18.7%
0.00%0.0%
Q2 2022$3,718,000
-38.1%
180,511
-3.4%
0.00%0.0%
Q1 2022$6,011,000
+25.8%
186,800
+82.0%
0.00%0.0%
Q4 2021$4,777,000
+147.6%
102,614
+43.6%
0.00%
Q3 2021$1,929,000
+29.4%
71,460
+22.9%
0.00%
Q2 2021$1,491,000
-20.9%
58,130
+5.5%
0.00%
Q1 2021$1,884,000
+35.0%
55,111
+33.6%
0.00%
Q4 2020$1,396,000
+94.4%
41,260
+41.9%
0.00%
Q3 2020$718,00029,0690.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders